<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2026.1728579</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Research Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Photobiomodulation (PBM) irradiation enhances the therapeutic potential of hMSC spheroids for neural repair</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Chang</surname>
<given-names>So-Young</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Hong</surname>
<given-names>Namgue</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2615733"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Ji Eun</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1326552"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Ahn</surname>
<given-names>Jin-Chul</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn00001"><sup>&#x2021;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Lee</surname>
<given-names>Min Young</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn00001"><sup>&#x2021;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1559322"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Beckman Laser Institute Korea, Dankook University</institution>, <city>Cheonan</city>, <country country="kr">Republic of Korea</country></aff>
<aff id="aff2"><label>2</label><institution>Medical Laser Research Center, College of Medicine, Dankook University</institution>, <city>Cheonan</city>, <country country="kr">Republic of Korea</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Otolaryngology-Head &#x0026; Neck Surgery, College of Medicine, Dankook University</institution>, <city>Cheonan</city>, <country country="kr">Republic of Korea</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Jin-Chul Ahn, <email xlink:href="mailto:jcahn@dankook.ac.kr">jcahn@dankook.ac.kr</email>; Min Young Lee, <email xlink:href="mailto:eyeglass210@gmail.com">eyeglass210@gmail.com</email></corresp>
<fn fn-type="equal" id="fn0001"><label>&#x2020;</label><p>These authors have contributed equally to this work and share first authorship</p></fn>
<fn fn-type="equal" id="fn00001"><label>&#x2021;</label><p>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-29">
<day>29</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>20</volume>
<elocation-id>1728579</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>01</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Chang, Hong, Choi, Ahn and Lee.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Chang, Hong, Choi, Ahn and Lee</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-29">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Neural regeneration remains a critical goal in regenerative medicine, especially for treating central nervous system injuries such as stroke, spinal cord injury, and neurodegenerative diseases. Mesenchymal stem cells (MSCs) have shown therapeutic potential through their capacity for differentiation and paracrine signaling; however, their clinical application is limited by low survival and engraftment rates. In this study, we investigated whether the therapeutic efficacy of human MSC (hMSC) spheroids could be enhanced through photobiomodulation (PBM). hMSCs were aggregated into three-dimensional spheroids and divided into four experimental groups: (1) untreated control spheroids, (2) spheroids treated with 660&#x202F;nm PBM, (3) spheroids treated with 850&#x202F;nm PBM, and (4) spheroids co-cultured with primary rat cortical neurons subjected to oxidative stress using hydrogen peroxide (H&#x2082;O&#x2082;). The PBM groups were exposed to red (660&#x202F;nm) or near-infrared (NIR; 850&#x202F;nm) light for 10&#x202F;min. Neuronal viability and axonal regeneration were assessed. Our results demonstrated that PBM-treated hMSC spheroids significantly increased neuronal survival and axonal outgrowth compared to H&#x2082;O&#x2082;-only controls, particularly under high oxidative stress conditions. Notably, spheroids treated with 850&#x202F;nm PBM exhibited the most robust neuroprotective effects. These findings suggest that PBM enhances mitochondrial activity and the secretion of neurotrophic factors by hMSC spheroids, thereby promoting neuroregeneration. This combinatorial strategy integrating PBM with 3D stem cell spheroid culture offers a promising avenue for developing advanced stem cell therapies for neurological disorders.</p>
</abstract>
<kwd-group>
<kwd>hydrogen peroxide</kwd>
<kwd>mesenchymal stem cells</kwd>
<kwd>neural regeneration</kwd>
<kwd>oxidative stress</kwd>
<kwd>photobiomodulation</kwd>
<kwd>spheroids</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>National Research Foundation</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100001321</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">
<institution-wrap>
<institution>National Research Foundation of Korea (NRF) funded by the Ministry of Education</institution>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (RS-2020-NR049585; RS-2021-NR065982), and Bio&#x0026;Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) [RS-2023-00220408]. The Dankook Biomed Animal Facility was supported through the Research-Focused Department Promotion &#x0026; Interdisciplinary Convergence Research Project as a part of the Support Program for University Development for Dankook University in 2025.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="45"/>
<page-count count="11"/>
<word-count count="7765"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Neuropathology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Neural regeneration remains a critical goal in the field of regenerative medicine, with the potential to treat a wide range of neurological disorders such as peripheral nerve injuries, spinal cord injuries, stroke, Parkinson&#x2019;s disease, and traumatic brain injuries (<xref ref-type="bibr" rid="ref24">Kvistad et al., 2024</xref>; <xref ref-type="bibr" rid="ref45">Zhu et al., 2025</xref>; <xref ref-type="bibr" rid="ref25">Li et al., 2023</xref>; <xref ref-type="bibr" rid="ref2">Andrzejewska et al., 2021</xref>; <xref ref-type="bibr" rid="ref40">Yarahmadi, 2025</xref>; <xref ref-type="bibr" rid="ref35">Rao et al., 2022</xref>; <xref ref-type="bibr" rid="ref22">Kim and Kwak, 2025</xref>; <xref ref-type="bibr" rid="ref3">Arslan et al., 2024</xref>). Achieving effective repair of neural structures requires innovative approaches that can stimulate the body&#x2019;s inherent healing capabilities. Traditional therapeutic strategies for these disorders, such as pharmacological agents, surgery, and physical rehabilitation, often fall short of restoring damaged neural tissues or achieving sustained functional recovery, thereby highlighting the urgent need for more effective regenerative approaches (<xref ref-type="bibr" rid="ref5">Carter et al., 2019</xref>). Among these approaches, stem cell-based therapies have gained significant attention due to their ability to replace damaged cells and modulate the local microenvironment through paracrine signaling (<xref ref-type="bibr" rid="ref36">Wang et al., 2025</xref>; <xref ref-type="bibr" rid="ref42">Zeng, 2023</xref>; <xref ref-type="bibr" rid="ref44">Zhidu et al., 2024</xref>; <xref ref-type="bibr" rid="ref39">Xue et al., 2024</xref>; <xref ref-type="bibr" rid="ref4">Carpena et al., 2025</xref>; <xref ref-type="bibr" rid="ref7">Chang, 2023</xref>; <xref ref-type="bibr" rid="ref8">Chang and Lee, 2021</xref>; <xref ref-type="bibr" rid="ref1">Abueva et al., 2025</xref>).</p>
<p>Stem cells&#x2014;particularly mesenchymal stem cells (MSCs)&#x2014;are capable of differentiating into various cell types, including neurons, glial cells, and other supportive tissues (<xref ref-type="bibr" rid="ref13">George et al., 2019</xref>; <xref ref-type="bibr" rid="ref38">Xu et al., 2024</xref>). Beyond differentiation, they secrete neurotrophic factors such as the brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), and other cytokines, which promote neuroprotection, angiogenesis, and tissue repair (<xref ref-type="bibr" rid="ref20">Isakovic, 2023</xref>). For example, MSCs have been utilized in experimental models to improve functional recovery after spinal cord injury by reducing inflammation and promoting axonal growth. Nevertheless, their therapeutic potential in clinical settings is often hampered by poor cell survival, limited engraftment, and inconsistent functional outcomes following transplantation (<xref ref-type="bibr" rid="ref23">Kusuma, 2022</xref>).</p>
<p>The three-dimensional organization of stem cells into spheroids offers several key advantages over traditional monolayer cultures or dispersed single cells (<xref ref-type="bibr" rid="ref34">Petrenko et al., 2017</xref>; <xref ref-type="bibr" rid="ref41">Yen et al., 2023</xref>). Spheroid formation enhances cell&#x2013;cell and cell&#x2013;extracellular matrix (ECM) interactions, increases survival rates, and amplifies the secretion of therapeutic factors (<xref ref-type="bibr" rid="ref41">Yen et al., 2023</xref>; <xref ref-type="bibr" rid="ref37">Xu, 2016</xref>). For instance, MSC spheroids have demonstrated enhanced secretion of neurotrophic factors compared to single-cell suspensions, leading to improved outcomes in laboratory models of nerve injury. This 3D configuration also more closely mimics the <italic>in vivo</italic> microenvironment, providing structural and biochemical cues essential for maintaining stem cell potency and function (<xref ref-type="bibr" rid="ref21">Jaukovic, 2020</xref>).</p>
<p>Photobiomodulation (PBM), a non-invasive light therapy, has also been shown to bolster cellular activity and enhance the therapeutic potential of stem cells (<xref ref-type="bibr" rid="ref7">Chang, 2023</xref>; <xref ref-type="bibr" rid="ref8">Chang and Lee, 2021</xref>; <xref ref-type="bibr" rid="ref1">Abueva et al., 2025</xref>; <xref ref-type="bibr" rid="ref6">Chang, 2020</xref>; <xref ref-type="bibr" rid="ref32">Park, 2022</xref>; <xref ref-type="bibr" rid="ref17">Hong et al., 2022</xref>). PBM is most commonly applied within the red to near-infrared (NIR) spectrum, typically ranging from 600 to 1,000&#x202F;nm, due to its favorable tissue penetration and interaction with mitochondrial photoacceptors, such as cytochrome c oxidase (<xref ref-type="bibr" rid="ref43">Zhang et al., 2024</xref>; <xref ref-type="bibr" rid="ref12">Fernandes et al., 2024</xref>).</p>
<p>PBM acts primarily by stimulating mitochondrial cytochrome c oxidase, thereby increasing ATP production, modulating reactive oxygen species, and improving cell proliferation, differentiation, and survival (<xref ref-type="bibr" rid="ref14">Hamblin, 2018</xref>; <xref ref-type="bibr" rid="ref9">Chang et al., 2019</xref>).</p>
<p>Recent systematic reviews have highlighted that PBM within this wavelength range plays an important role in modulating neural signaling pathways and cellular bioenergetics, underscoring the importance of wavelength selection and parameter optimization for neural repair and other biomedical applications (<xref ref-type="bibr" rid="ref43">Zhang et al., 2024</xref>; <xref ref-type="bibr" rid="ref12">Fernandes et al., 2024</xref>). Within this wavelength range, PBM has been widely investigated for various biomedical applications, including neural repair, wound healing, and inflammation control. These effects are particularly beneficial for MSCs, as PBM has also been reported to rejuvenate aged or stressed cells by restoring mitochondrial function and boosting paracrine signaling (<xref ref-type="bibr" rid="ref23">Kusuma, 2022</xref>; <xref ref-type="bibr" rid="ref19">Hung et al., 2022</xref>).</p>
<p>When combined with MSC spheroids, PBM can further amplify their regenerative effects, making this a promising strategy for neural repair (<xref ref-type="bibr" rid="ref31">Mulaudzi et al., 2024</xref>). However, most previous PBM studies have been conducted in monoculture systems or simple two-dimensional (2D) environments, which do not fully capture the complex cellular interactions involved in neural repair. Therefore, optimizing the activity and functionality of MSC spheroids prior to clinical application remains essential. Preconditioning strategies, such as PBM, can enhance therapeutic efficacy, leading to better integration, survival, and functional recovery in injured neural tissues. Improving the potency of MSC spheroids through such methods is a vital step toward translating these promising therapies from laboratory research to real-world clinical treatments.</p>
<p>In this study, we explored the regenerative potential of human MSC (hMSC) spheroids preconditioned with PBM at different wavelengths in a hybrid co-culture system. Unlike previous studies that primarily focused on PBM effects in single-cell populations or homogeneous culture models, our approach integrated three-dimensional hMSC spheroids with a primary rat cortical neuron monolayer, enabling the investigation of PBM-mediated neuron&#x2013;stem cell interactions in a spatially organized <italic>in vitro</italic> environment. These spheroids were co-cultured with primary rat cortical neurons that had been damaged by hydrogen peroxide (H&#x2082;O&#x2082;)-induced oxidative stress, a model that mimics aspects of neural injury and degeneration.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<sec id="sec3">
<title>Animals</title>
<p>All experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Dankook University Medical School (approval number: DKU-23-058) and were conducted in accordance with the National Institutes of Health (NIH) guidelines for the care and use of laboratory animals. Furthermore, we confirm that all procedures are reported in compliance with the ARRIVE guidelines. Animals were housed under a 12-h light/dark cycle with free access to standard food pellets and water.</p>
</sec>
<sec id="sec4">
<title>Primary culture of cortical neurons</title>
<p>Primary cortical neurons were prepared from embryonic day 17 (E17) Sprague&#x2013;Dawley rat fetuses, as previously described with minor modifications (<xref ref-type="bibr" rid="ref18">Hong et al., 2023</xref>). Pregnant rats were anesthetized with 16.5% urethane, and the fetal cortices were dissected in calcium- and magnesium-free HEPES-buffered Hank&#x2019;s balanced salt solution (pH 7.45, Gibco, Life Technologies Corporation, NY, United States). Cortical tissues were gently dissociated using a series of flame-polished Pasteur pipettes. The dissociated cells were seeded at a density of 1.6&#x202F;&#x00D7;&#x202F;10<sup>4</sup> cells/well onto 25-mm glass coverslips pre-coated with 0.2&#x202F;mg/mL Matrigel (Corning, Bedford, MA, United States) for 1&#x202F;h. Neurons were maintained in Neurobasal medium supplemented with 2% B27 (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, United States), 0.25% GlutaMAX-I(Gibco; Life Technologies Corporation), 100&#x202F;U/mL penicillin, 100&#x202F;&#x03BC;g/mL streptomycin, and 0.025&#x202F;&#x03BC;g/mL amphotericin B (Sigma-Aldrich, St. Louis, MO, United States) in a humidified incubator (10% CO&#x2082;, 90% air, 37&#x202F;&#x00B0;C, pH 7.4). The medium was replenished every 4&#x202F;days by replacing 75% of the volume with fresh medium. All experiments were conducted using six independent cultures. On day <italic>in vitro</italic> (DIV) 13, neurons were exposed to either 10&#x202F;&#x03BC;M or 100&#x202F;&#x03BC;M hydrogen peroxide (H&#x2082;O&#x2082;) for 30&#x202F;min, after which the medium was completely replaced with fresh culture medium.</p>
</sec>
<sec id="sec5">
<title>Human mesenchymal stem cell isolation, culture, and spheroid production</title>
<p>This study was approved by the Institutional Review Board of Dankook University Hospital (Approval No. DKUH-2020-05-001), and all procedures were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all donors prior to the collection of human-derived biological materials (hMSCs). The manuscript does not contain any personally identifiable information of the donors other than age and sex. A 50-year-old female patient who provided informed consent prior to surgery participated in this study. Cell sorting and differentiation were performed by N-BIOTEK (Bucheon-si, Gyeonggi-do, 14,502, Republic of Korea), which is an officially approved stem cell engineering center by the Korean Government. Further information is provided in a previous publication (<xref ref-type="bibr" rid="ref10">Chang et al., 2023</xref>). hMSCs were isolated from human adipose tissue. The adipose tissue was washed three times with 1X phosphate-buffered saline (PBS) and digested with 0.1% (w/v) type I collagenase (Nordmark, Uetersen, Germany) for 45&#x202F;min at 37&#x202F;&#x00B0;C. Undigested tissue and excess oil were filtered out using a screen mesh, followed by centrifugation at 1500&#x202F;rpm for 5&#x202F;min. The passage number used in the experiment was passage 4. hMSCs were cultured in <italic>&#x03B1;</italic>-MEM (Corning) supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin&#x2013;streptomycin at 37&#x202F;&#x00B0;C in a 5% CO&#x2082; incubator. To confirm the characteristics of the hMSC spheroids, the expression of CD73 (Invitrogen, 41&#x2013;0200), CD90 (Abcam, ab307736), and CD105 (Invitrogen, MA5-17041) was examined as a positive marker, while CD45 (Abcam, ab10558) was examined as a negative marker. Cells were seeded in 90&#x202F;mm culture dishes and subcultured when they reached approximately 80&#x2013;90% confluence. For spheroid formation, hMSCs were seeded in ultra-low attachment U-bottom 96-well plates (Sumitomo Bakelite Co., Ltd., Kobe, Japan) at a density of 3.5&#x202F;&#x00D7;&#x202F;10<sup>3</sup> cells per well in 100&#x202F;&#x03BC;L of complete medium. The plates were centrifuged at 1,000&#x202F;rpm for 3&#x202F;min to promote cell aggregation and then incubated for 48 h to allow spontaneous spheroid formation. At the time point when primary cortical neurons had established mature neuronal networks and hMSC spheroids had developed a compact and transferable structure, the two cell types were co-cultured. One hMSC spheroid was added to each well containing cortical neurons.</p>
</sec>
<sec id="sec6">
<title>Photobiomodulation and hMSC spheroid treatment</title>
<p>hMSC spheroids were irradiated with either 660&#x202F;nm (10&#x202F;mW/cm<sup>2</sup>) or 850&#x202F;nm (12&#x202F;mW/cm<sup>2</sup>) wavelength light for 10&#x202F;min prior to their application to cortical neuron cultures. On DIV 13, 30&#x202F;min after H&#x2082;O&#x2082; exposure, the irradiated hMSC spheroids were introduced to the neuronal cultures. PBM exposure was performed in the dark, and a power meter (PD300 and VEGA, Ophir Photonics) was used to confirm light intensity. Neurons were fixed 24&#x202F;h after H&#x2082;O&#x2082; treatment for subsequent analyses. To assess power density-dependent effects of PBM on spheroid-mediated neuroprotection, additional spheroid groups were irradiated at multiple power densities prior to co-culture. For 660&#x202F;nm PBM, spheroids were exposed at 5, 10, or 20&#x202F;mW/cm<sup>2</sup>, and for 850&#x202F;nm PBM at 6, 12, or 24&#x202F;mW/cm<sup>2</sup> (10&#x202F;min), followed by co-culture under H&#x2082;O&#x2082; injury conditions and MTT assessment at 24&#x202F;h (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>).</p>
</sec>
<sec id="sec7">
<title>Immunocytochemistry</title>
<p>Cortical neurons and hMSC spheroids were fixed with cold methanol (&#x2212;20&#x202F;&#x00B0;C) for 8&#x202F;min. After fixation, cells were permeabilized with 0.3% Triton X-100 for 5&#x202F;min and blocked with 10% bovine serum albumin (BSA) for 1&#x202F;h. Neuronal samples were incubated overnight at 4&#x202F;&#x00B0;C with a primary antibody against mouse anti-MAP2 (Sigma-Aldrich, M9942), followed by incubation with an Alexa Fluor 555-conjugated anti-mouse IgG secondary antibody (ThermoFisher, A21422). For the immunophenotypic characterization of hMSC spheroids, the samples were stained with primary antibodies against CD73 (Invitrogen, 41&#x2013;0200), CD90 (Abcam, ab307736), CD105 (Invitrogen, MA5-17041), and CD45 (Abcam, ab10558), followed by appropriate Alexa Fluor 488-conjugated secondary antibodies. After staining, all samples were mounted with VECTASHIELD Antifade Medium containing DAPI (Vector Laboratories, H-1200) and imaged using a confocal microscope (FV3000, Olympus, Tokyo, Japan). Excitation/emission wavelengths for Alexa Fluor 488 and 555 were 488/520&#x202F;nm and 561/568&#x202F;nm, respectively.</p>
</sec>
<sec id="sec8">
<title>Microscopic imaging and quantification</title>
<p>Confocal imaging was performed using a 20&#x202F;&#x00D7;&#x202F;objective on an FV3000 microscope (Olympus). Z-stacked images were acquired across 10&#x202F;&#x03BC;m (1&#x202F;&#x03BC;m step size) and merged into a single maximum intensity projection. For each condition, 3&#x2013;4 random fields were captured. MAP2-labeled dendritic structures were visualized and analyzed using the Metamorph software (Molecular Devices) to assess dendritic morphology in primary cortical neurons.</p>
</sec>
<sec id="sec9">
<title>MTT and BDNF ELISA assay</title>
<p>To evaluate cell viability, cortical neurons were treated with H&#x2082;O&#x2082; and hMSC spheroids. After 24&#x202F;h, cells were incubated for 4&#x202F;h with 0.5&#x202F;mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich). The resulting formazan crystals were dissolved in dimethyl sulfoxide, and absorbance was measured at 570&#x202F;nm using a microplate reader. The levels of neurotrophic and angiogenic factors secreted by hMSC spheroids were quantified using enzyme-linked immunosorbent assays (ELISA). Brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and vascular endothelial growth factor (VEGF) concentrations in culture supernatants were measured using the following commercially available human ELISA kits: Human BDNF SimpleStep ELISA Kit (ab212166, Abcam, United Kingdom), Human NGF ELISA Kit (ab193760, Abcam, United Kingdom), and Human VEGF ELISA Kit (ab222510, Abcam, United Kingdom), according to the manufacturers&#x2019; instructions. Briefly, culture media were collected immediately after the PBM treatment of hMSC spheroids, centrifuged at 2,000&#x202F;&#x00D7;&#x202F;g for 5&#x202F;min to remove cellular debris, and stored at &#x2212;20&#x202F;&#x00B0;C until analysis. For each assay, standards and samples (50&#x202F;&#x03BC;L per well) were added to pre-coated 96-well plates, followed by the addition of the corresponding antibody cocktail. The plates were incubated for 1&#x202F;h at room temperature with gentle shaking. After washing, tetramethylbenzidine (TMB) substrate solution was added, and the reaction was stopped using stop solution. Absorbance was measured at 450&#x202F;nm using a microplate reader. All samples were analyzed in duplicate, and concentrations were calculated based on standard curves generated for each factor.</p>
</sec>
<sec id="sec10">
<title>Statistical analysis</title>
<p>The results were analyzed using the Prism software 8.4.3 (GraphPad Software, La Jolla, CA, United States; RRID: SCR_002798). Normality of the data distribution was assessed prior to statistical analysis. Two-tailed Mann&#x2013;Whitney U tests (non-parametric) and unpaired non-parametric <italic>t</italic>-tests were performed to compare the hMSC size over time, as these datasets did not meet the assumptions of normality and involved independent group comparisons. One-way repeated measure analysis of variance (ANOVA) followed by Tukey&#x2019;s multiple comparisons tests was used to compare cell viability, axonal length, and branch number, as these parameters were measured repeatedly across multiple experimental conditions within the same samples and met parametric assumptions. <italic>p</italic>-values &#x003C; 0.05 were considered to indicate significance. All statistical comparisons and corresponding <italic>p</italic>-values for each figure are summarized in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Summary of statistical analyses and <italic>p</italic>-values corresponding to each figure.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Figure</th>
<th align="left" valign="top">Test type</th>
<th align="left" valign="top">Comparison</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig1">Figure 1D</xref>
</td>
<td align="left" valign="top">Unpaired <italic>t</italic>-test</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig1">Figure 1F</xref>
</td>
<td align="left" valign="top">Unpaired <italic>t</italic>-test</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2A</xref>
</td>
<td align="left" valign="top">One-way ANOVA</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0004</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2A</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (10&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0016</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">One-way ANOVA</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;660&#x202F;nm</td>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0006</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;850&#x202F;nm</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0013</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;660&#x202F;nm</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0066</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig2">Figure 2B</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;850&#x202F;nm</td>
<td align="center" valign="top">&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0148</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3D</xref>
</td>
<td align="left" valign="top">One-way ANOVA</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3D</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (10&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0015</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3D</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0023</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3D</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;660&#x202F;nm</td>
<td align="center" valign="top">&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0148</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3D</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;850&#x202F;nm</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0083</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">One-way ANOVA</td>
<td/>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (10&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0008</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">Control vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0019</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (10&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (10&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;850&#x202F;nm</td>
<td align="center" valign="top">&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0263</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;660&#x202F;nm</td>
<td align="center" valign="top">&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0122</td>
</tr>
<tr>
<td align="left" valign="top">
<xref ref-type="fig" rid="fig3">Figure 3E</xref>
</td>
<td align="left" valign="top">Tukey&#x2019;s multiple comparisons</td>
<td align="left" valign="top">H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M) vs. H<sub>2</sub>O<sub>2</sub> (100&#x202F;&#x03BC;M)&#x202F;+&#x202F;SP&#x202F;+&#x202F;850&#x202F;nm</td>
<td align="center" valign="top">&#x002A;&#x002A;<italic>p</italic>&#x202F;=&#x202F;0.0102</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>This table presents the statistical tests performed, the group comparisons made, and the resulting <italic>p</italic>-values associated with the data shown in the figures. &#x002A;Statistically significant.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<title>Results</title>
<sec id="sec12">
<title>Characteristics of the primary cortical neurons and hMSCs</title>
<p>To resemble regenerating neurons from various types of neuronal damage, primary cortical neurons were harvested from rat pups and cultured (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). With the appropriate application of factors (see methods), the initially heterogeneous cell population gradually became homotypic, consisting of neural cells with axonal network connections (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). These axonal connections were identified through epifluorescence analysis of MAP2 antibody expression. hMSCs were aggregated into spheroids (using the cell number of 3.5&#x202F;&#x00D7;&#x202F;10<sup>3</sup>), and these spheroids were structurally stable for over 48&#x202F;h (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The average size of the hMSC spheroid reached 300&#x202F;&#x03BC;m 48&#x202F;h after initial cell seeding for spheroid formation, showing a statistically significant increase compared to 24&#x202F;h (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). To verify the characteristics of hMSC spheroids, the expression of representative hMSC markers was examined. Among these, the positive markers CD73, CD90, and CD105 were expressed (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). The hMSC spheroids were divided into three groups: a spheroid-only group that received no additional treatment, a 660&#x202F;nm PBM group irradiated for 10&#x202F;min, and an 850&#x202F;nm PBM group irradiated for 10&#x202F;min. After this short PBM preconditioning, the hMSC spheroids were co-cultivated with primary cortical neuronal networks that had been damaged with varying concentrations of H<sub>2</sub>O<sub>2</sub> (10 or 100&#x202F;&#x03BC;M for 30&#x202F;min; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). A quantitative comparison of secreted neurotrophic and angiogenic factors in hMSC spheroids after PBM treatment was conducted. ELISA analysis revealed that PBM-treated hMSC spheroids exhibited significantly higher levels of the BDNF, NGF, and VEGF compared to non-PBM-treated spheroids (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), indicating an enhanced paracrine secretory profile following PBM preconditioning.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Experimental strategies using primary cortical neuron culture and photobiomodulation (PBM)-irradiated hMSC spheroids. <bold>(A)</bold> Primary cortical neurons were harvested from rat embryos at embryonic day 17 (E17) and cultured under conditions that promote axonal sprouting and cell&#x2013;cell network formation (day &#x2212;7 to day 1). In parallel, hMSCs were seeded in round-bottom 96-well plates to generate spheroids (day &#x2212;2). On day 0, two-thirds of the hMSC spheroids were irradiated with photobiomodulation (PBM) at either 660&#x202F;nm (10&#x202F;mW, 10&#x202F;min) or 850&#x202F;nm (12&#x202F;mW, 10&#x202F;min), while the remaining spheroids were left unexposed. Primary cortical neurons were then exposed to cytotoxic H&#x2082;O&#x2082; (10 or 100&#x202F;&#x03BC;M for 30&#x202F;min) and subsequently co-cultured with hMSC spheroids with or without PBM treatment. Samples were collected on day 1 for cell viability and epifluorescence analyses. <bold>(B)</bold> Immediately after seeding, cortical cells exhibited heterogeneous morphology with high cell density (day &#x2212;7). Following cultivation under neural differentiation conditions, cell density decreased and cells displayed more homogeneous neuronal morphology. MAP2 immunostaining revealed extensive axonal network formation on day 0. <bold>(C)</bold> hMSCs exhibited spindle-shaped morphology prior to spheroid aggregation. <bold>(D)</bold> Following spheroid formation, the spheroid diameter increased over time, showing a statistically significant enlargement at 48&#x202F;h compared to 24&#x202F;h after initial formation (&#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C;&#x202F;0.0001). <bold>(E)</bold> Characterization of hMSC spheroids by immunocytochemical staining for representative surface markers CD73, CD90, and CD105. <bold>(F)</bold> Quantification of BDNF levels in hMSC spheroids following PBM treatment (&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001).</p>
</caption>
<graphic xlink:href="fncel-20-1728579-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Composite image displaying an experimental setup for hMSC spheroid preparation and primary cortical neuron culture. (A) Diagram illustrating the timeline and treatment process involving hydrogen peroxide and photobiomodulation at 660 nm and 850 nm. (B) Microscopic images of neuron cultures at different time points with MAP2 staining. (C) Formation of hMSC spheroids shown in micrographs with different markers CD73, CD90, CD105 at various stages. (D) Bar chart comparing spheroid sizes at 24 and 48 hours. (E) Fluorescent images of spheroids with DAPI and CD markers. (F) Bar chart illustrating human BDNF levels under different conditions.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec13">
<title>Cell viability alterations in response to hMSC spheroids, with or without PBM treatment, under H<sub>2</sub>O<sub>2</sub>-induced toxicity</title>
<p>H<sub>2</sub>O<sub>2</sub> exposure represents a cytotoxic stimulus that can cause damage to neuronal cells. Exposure to 10&#x202F;&#x03BC;M H&#x2082;O&#x2082; resulted in a significant reduction in cell viability to approximately 75% relative to the control (<italic>p</italic>&#x202F;=&#x202F;0.0016; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). At higher H<sub>2</sub>O<sub>2</sub> concentrations, cell viability was drastically decreased to 21% (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001; <xref ref-type="fig" rid="fig2">Figure 2B</xref>). To investigate the neuronal regenerative potential of hMSCs in an H<sub>2</sub>O<sub>2</sub> toxicity model, hMSC spheroids, with or without PBM preconditioning (660&#x202F;nm or 850&#x202F;nm), were co-incubated with primary cortical neurons exposed to H&#x2082;O&#x2082;. Under low H<sub>2</sub>O<sub>2</sub> concentration conditions, co-incubation with various hMSC spheroids did not alter cell viability (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In contrast, under high H<sub>2</sub>O<sub>2</sub> concentration conditions, co-incubation with hMSC spheroids led to an increase in cell viability. Notably, both 660&#x202F;nm- and 850&#x202F;nm-PBM-treated hMSC spheroids significantly improved cell viability compared to the H&#x2082;O&#x2082;-only group and the spheroid group without PBM (<italic>p</italic>&#x202F;=&#x202F;0.0006 for 660&#x202F;nm vs. H&#x2082;O&#x2082; only; <italic>p</italic>&#x202F;=&#x202F;0.0013 for 850&#x202F;nm vs. H&#x2082;O&#x2082; only; <xref ref-type="fig" rid="fig2">Figure 2B</xref>). To assess whether PBM efficacy depends on irradiation power density, we performed a power titration for each wavelength prior to spheroid application (660&#x202F;nm: 5/10/20&#x202F;mW/cm<sup>2</sup>; 850&#x202F;nm: 6/12/24&#x202F;mW/cm<sup>2</sup>; 10&#x202F;min). While PBM power titration did not markedly alter viability under low oxidative stress conditions, several power settings improved viability under high H&#x2082;O&#x2082; conditions, indicating that PBM effects on hMSC spheroid-mediated neuroprotection are parameter-sensitive (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Effects of PBM-treated hMSC spheroids on neuronal viability assessed by MTT assay. <bold>(A)</bold> Neuronal cell viability was significantly reduced following exposure to low concentrations of H&#x2082;O&#x2082; (10&#x202F;&#x03BC;M for 30&#x202F;min); however, co-culture with hMSC spheroids did not significantly alter cell viability under these conditions (&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01). <bold>(B)</bold> Exposure to high concentrations of H&#x2082;O&#x2082; (100&#x202F;&#x03BC;M for 30&#x202F;min) markedly decreased neuronal cell viability. Co-culture with PBM-treated hMSC spheroids at both 660&#x202F;nm and 850&#x202F;nm wavelengths significantly improved cell viability compared to neurons exposed to H&#x2082;O&#x2082; alone or co-cultured with non-PBM-treated spheroids (&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.0001).</p>
</caption>
<graphic xlink:href="fncel-20-1728579-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar charts labeled A and B display cell viability percentages under varying conditions. In chart A, treatment with hydrogen peroxide and hMSC SP shows decreased viability compared to controls, with no significant difference among photobiomodulation (PBM) treatments. In chart B, hydrogen peroxide at a higher concentration shows reduced viability, with significant increases when combined with PBM, particularly at 850 nanometers. Asterisks indicate statistical significance levels, with "ns" meaning not significant.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec14">
<title>Observation of axonal loss and re-sprouting, and their modulation by hMSC spheroids, with or without PBM treatment, under H<sub>2</sub>O<sub>2</sub>-induced toxicity</title>
<p>Primary cortical neurons were exposed to cytotoxic H<sub>2</sub>O<sub>2</sub> (10 or 100&#x202F;&#x03BC;M for 30&#x202F;min) and subsequently co-cultivated with spheroids, with or without PBM. On day 1, samples were collected for cell viability assessment and epifluorescence analysis. After co-cultivation, hMSCs spread out, and some were in contact with primary cortical neurons (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). For microscopic analyses, areas not in contact with hMSCs were assessed. (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). After H<sub>2</sub>O<sub>2</sub> exposure, even at low concentrations, the number of cells observed in light microscopy (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and the number of neuronal cells (MAP2) in epifluorescence analysis (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) were significantly decreased. Epifluorescence analysis showed that the number of MAP2-expressing cells after high-concentration H<sub>2</sub>O<sub>2</sub> exposure was also significantly reduced (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). To evaluate the axonal re-sprouting potential of hMSCs in an H<sub>2</sub>O<sub>2</sub> toxicity model, the total outgrowth length and rate of branching were evaluated. Across all H<sub>2</sub>O<sub>2</sub> treatment conditions, axonal sprouting was decreased and shortened (<xref ref-type="fig" rid="fig3">Figures 3B</xref>,<xref ref-type="fig" rid="fig3">C</xref>). Under low-concentration H&#x2082;O&#x2082; conditions, sprouting frequency (branches) was reduced to 38.19&#x202F;&#x00B1;&#x202F;4.34% of control levels (<italic>p</italic> =&#x202F;0.0008), and total outgrowth length decreased to 45.48&#x202F;&#x00B1;&#x202F;4.35% of control levels (<italic>p</italic> =&#x202F;0.0015). Under high H&#x2082;O&#x2082; concentration conditions, sprouting frequency (branches) was reduced to 30.67&#x202F;&#x00B1;&#x202F;4.58% of control levels (<italic>p</italic> =&#x202F;0.0019), and total outgrowth length decreased to 37.28&#x202F;&#x00B1;&#x202F;5.13% of control levels (<italic>p</italic> =&#x202F;0.0023; <xref ref-type="fig" rid="fig3">Figures 3D</xref>,<xref ref-type="fig" rid="fig3">E</xref>). As shown in representative images after low H<sub>2</sub>O<sub>2</sub> exposure, the frequency of axonal branching was relatively higher in hMSC spheroid co-cultures, especially those involving PBM-treated hMSC spheroids (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). There was a statistically higher sprouting frequency in the 850&#x202F;nm PBM-treated hMSC spheroid co-incubation group (83.25&#x202F;&#x00B1;&#x202F;10.49% of control, <italic>p</italic> =&#x202F;0.0263) compared to the low-concentration H<sub>2</sub>O<sub>2</sub>-only group (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Under high H<sub>2</sub>O<sub>2</sub> concentration conditions, PBM-treated hMSC spheroids showed restoration of neurite parameters. Specifically, total outgrowth length increased to 94.19&#x202F;&#x00B1;&#x202F;15.79% (660&#x202F;nm, <italic>p</italic> =&#x202F;0.0148) and 101.49&#x202F;&#x00B1;&#x202F;11.71% (850&#x202F;nm, <italic>p</italic> =&#x202F;0.0083) of control levels (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), while branching frequency increased to 93.81&#x202F;&#x00B1;&#x202F;16.76% (660&#x202F;nm, <italic>p</italic> =&#x202F;0.0122) and 99.36&#x202F;&#x00B1;&#x202F;13.77% (850&#x202F;nm, <italic>p</italic> =&#x202F;0.0102) of control levels (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), compared to the H<sub>2</sub>O<sub>2</sub>-only group. To distinguish between direct cell&#x2013;cell interactions and paracrine-mediated effects, we compared a direct co-culture of hMSC spheroids with primary cortical neurons to an indirect co-culture system using 0.4&#x202F;&#x03BC;m Transwell inserts. The inserts physically prevent cell contact while allowing the diffusion of secreted factors. Quantitative analysis of MAP2-positive neurite outgrowth and branch density revealed that neuronal survival and axonal regeneration were comparably enhanced in both direct and Transwell co-culture conditions (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 2</xref>). These results indicate that the neuroprotective and neuritogenic effects of PBM-treated hMSC spheroids are predominantly mediated by paracrine signaling rather than direct cell&#x2013;cell contact.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Morphological analysis of axonal damage and re-sprouting. <bold>(A)</bold> Representative light microscopic images of primary cortical neuron cultures under four experimental conditions are shown. Control cultures exhibited high neuronal density prior to low-concentration H&#x2082;O&#x2082; exposure (10&#x202F;&#x03BC;M for 30&#x202F;min, day &#x2212;2). The remaining groups show cultures following H&#x2082;O&#x2082; treatment and subsequent co-culture with hMSC spheroids (white asterisks), with or without PBM treatment (660&#x202F;nm or 850&#x202F;nm). hMSCs dissociated from spheroids and spread into the surrounding area (open arrowheads). Dotted rectangles indicate regions analyzed for neuronal density that were not in direct contact with hMSCs. <bold>(B)</bold> Epifluorescence images of MAP2-stained neurons following low-concentration H&#x2082;O&#x2082; exposure (10&#x202F;&#x03BC;M). <bold>(C)</bold> Epifluorescence images of MAP2-stained neurons following high-concentration H&#x2082;O&#x2082; exposure (100&#x202F;&#x03BC;M). Open arrowheads indicate axonal sprouts. <bold>(D,E)</bold> Quantitative analysis of total axonal outgrowth length <bold>(D)</bold> and axonal branch density <bold>(E)</bold>. Under low-concentration H&#x2082;O&#x2082; conditions (10&#x202F;&#x03BC;M), total outgrowth length and branch density were reduced to 45.48&#x202F;&#x00B1;&#x202F;4.35% and 38.19&#x202F;&#x00B1;&#x202F;4.34% of control levels, respectively. Under high-concentration H&#x2082;O&#x2082; conditions (100&#x202F;&#x03BC;M), total outgrowth length and branch density were further reduced to 37.28&#x202F;&#x00B1;&#x202F;5.13% and 30.67&#x202F;&#x00B1;&#x202F;4.58% of control levels, respectively. Co-culture with PBM-treated hMSC spheroids significantly improved axonal parameters compared to the H&#x2082;O&#x2082;-only group. In particular, total outgrowth length increased to 94.19&#x202F;&#x00B1;&#x202F;15.79% (660&#x202F;nm) and 101.49&#x202F;&#x00B1;&#x202F;11.71% (850&#x202F;nm) of control levels, while branch density increased to 93.81&#x202F;&#x00B1;&#x202F;16.76% (660&#x202F;nm) and 99.36&#x202F;&#x00B1;&#x202F;13.77% (850&#x202F;nm) of control levels, under high-concentration H&#x2082;O&#x2082; conditions, indicating substantial recovery. Under low H&#x2082;O&#x2082; conditions (10&#x202F;&#x03BC;M), axonal parameters in the 850&#x202F;nm PBM-treated group were not significantly different from the control group, whereas the 660&#x202F;nm PBM-treated group remained significantly lower than control group. Under high H&#x2082;O&#x2082; conditions (100&#x202F;&#x03BC;M), neurite outgrowth and branch density in the 850&#x202F;nm PBM-treated group were not significantly different from the control group, indicating near-complete recovery. Data are presented as mean &#x00B1; SEM (&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001).</p>
</caption>
<graphic xlink:href="fncel-20-1728579-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">A scientific figure contains four panels. (A) Microscopy images show cells under various conditions: a control group, and groups exposed to hydrogen peroxide, spheroids, and photobiomodulation (PBM) at different wavelengths.(B) Immunofluorescence images of neurons labeled with MAP2 protein under the same conditions as in (A), highlighting differences in neural outgrowth.(C) Similar to (B) but with additional staining to show co-localization and cellular distribution effects across conditions.(D) A bar chart presents data on total outgrowth length as a percentage of control, with significant differences marked.(E) A bar chart shows the number of branches as a percentage of control, with statistical significance highlighted.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<title>Discussion</title>
<p>PBM has emerged as a promising adjunct to enhance the therapeutic efficacy of hMSCs in neural regeneration. A growing body of evidence indicates that PBM influences stem cell behavior through the modulation of mitochondrial activity, redox signaling, and gene expression (<xref ref-type="bibr" rid="ref6">Chang, 2020</xref>; <xref ref-type="bibr" rid="ref9">Chang et al., 2019</xref>). Specifically, PBM has been shown to improve stem cell viability, modulate differentiation pathways, and stimulate the secretion of biologically active paracrine factors that support tissue repair (<xref ref-type="bibr" rid="ref8">Chang and Lee, 2021</xref>; <xref ref-type="bibr" rid="ref6">Chang, 2020</xref>). Mitochondrial chromophores, particularly cytochrome c oxidase, absorb light in the red to near-infrared spectrum, enhancing adenosine triphosphate (ATP) production while reducing oxidative stress (<xref ref-type="bibr" rid="ref33">Perry et al., 2018</xref>; <xref ref-type="bibr" rid="ref11">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="ref30">Moore, 2020</xref>). The selection of PBM wavelengths within this spectral range is therefore biologically relevant and has been widely adopted in both preclinical and clinical studies. In addition to the effects of light itself, the use of 3D hMSC spheroids provides an additional layer of therapeutic enhancement. Compared to traditional 2D monolayer cultures, hMSC spheroids exhibit greater stemness, improved secretion of growth factors, and increased survival under stress conditions. These effects are largely attributed to enhanced cell&#x2013;cell and cell&#x2013;matrix interactions within the 3D structure, as well as the formation of physiologic gradients that simulate the <italic>in vivo</italic> environment. The hypoxic and mechanical cues within spheroids are known to upregulate genes associated with angiogenesis, immunomodulation, and neuroprotection (<xref ref-type="bibr" rid="ref26">Li et al., 2021</xref>; <xref ref-type="bibr" rid="ref16">Hill et al., 2021</xref>). Importantly, the combination of PBM with hMSC spheroids may result in additive or synergistic effects, enhancing both the intrinsic regenerative capacity of the cells and their responsiveness to injury cues.</p>
<p>In the present study, hMSC spheroids were preconditioned with PBM at different wavelengths and applied to an oxidative injury model using primary rat cortical neurons exposed to hydrogen peroxide (H&#x2082;O&#x2082;). As expected, H&#x2082;O&#x2082; caused significant neuronal cell death and disrupted axonal morphology. However, co-incubation with PBM-treated hMSC spheroids significantly improved neuronal viability and promoted axonal re-sprouting. Notably, spheroids preconditioned with 850&#x202F;nm light demonstrated the most robust neuroprotective effects, suggesting wavelength-dependent biological responses. The comparison between 660&#x202F;nm and 850&#x202F;nm wavelengths was intentionally chosen to represent the red and near-infrared regions most commonly used in PBM, allowing the evaluation of potential wavelength-specific differences in cellular activation, tissue penetration, and regenerative efficacy. This observation is consistent with previous findings showing that high wavelength light provides optimal tissue penetration and is most effective in activating cytochrome c oxidase, thus promoting mitochondrial respiration and reducing intracellular ROS levels (<xref ref-type="bibr" rid="ref11">Chen et al., 2019</xref>).</p>
<p>The beneficial effects observed in this study may involve enhanced metabolic support and paracrine signaling; however, it should be noted that the present study was not designed to delineate specific intracellular signaling pathways. PBM has been widely reported to influence mitochondrial bioenergetics and redox balance in various cell types, including mesenchymal stem cells, primarily through interactions with mitochondrial chromophores such as cytochrome c oxidase. Consistent with these previous observations, PBM-treated hMSC spheroids in our study exhibited enhanced secretion of neurotrophic and angiogenic factors. Importantly, we experimentally confirmed increased levels of the BDNF, NGF, and VEGF in PBM-treated hMSC spheroids using ELISA, providing direct evidence of enhanced paracrine output rather than downstream signaling activation. These secreted factors are well known to support neuronal survival, axonal regeneration, synaptic plasticity, and local angiogenesis, thereby creating a permissive microenvironment for neural repair (<xref ref-type="bibr" rid="ref29">Monika and Anna, 2019</xref>; <xref ref-type="bibr" rid="ref27">Liechti et al., 2017</xref>). While the upstream molecular regulators governing PBM-induced changes in hMSC spheroid function were not directly examined in this study, the observed functional outcomes strongly support a paracrine-mediated neuroprotective mechanism. Transwell-based co-culture experiments further support a paracrine-dominant mechanism, as comparable neuroprotective and neuritogenic effects were observed in the absence of direct cell&#x2013;cell contact. While direct physical interactions between hMSCs and neurons may contribute to localized effects <italic>in vivo</italic>, our data indicate that secreted factors from PBM-preconditioned hMSC spheroids are sufficient to drive neuronal survival and axonal regeneration under oxidative stress conditions.</p>
<p>Despite these promising results, it should be emphasized that the present study was designed as an <italic>in vitro</italic> proof-of-concept investigation, focusing specifically on oxidative stress-mediated neuronal damage. The H&#x2082;O&#x2082;-induced injury model was intentionally used as a controlled and reproducible system to isolate the effects of oxidative stress and to evaluate the paracrine-mediated neuroprotective potential of PBM-preconditioned hMSC spheroids under defined conditions. Although the results are promising, several limitations must be addressed. First, the <italic>in vitro</italic> H&#x2082;O&#x2082; model, while convenient and reproducible, does not fully capture the complexity of <italic>in vivo</italic> neural injury, which may involve excitotoxicity, inflammation, and blood&#x2013;brain barrier disruption. Second, although the main experiments compared two clinically relevant wavelengths at fixed irradiation settings, comprehensive PBM optimization (e.g., varying duration, repetition cycles, and treatment frequency) was beyond the scope of this proof-of-concept study. To partially address parameter dependence, we additionally performed a power density titration for each wavelength and observed power-dependent trends in neuroprotection under high oxidative stress (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>); nevertheless, further systematic optimization will be required for translational protocol development. Third, although this study demonstrates enhanced neurotrophic factor secretion following PBM treatment, it does not identify the specific intracellular signaling pathways responsible for these changes. Future studies incorporating transcriptomic, proteomic, or pathway-specific analyses will be necessary to elucidate the molecular mechanisms underlying PBM-mediated modulation of hMSC spheroids. In addition, although immunocytochemical analyses were performed to assess cellular and neuronal characteristics, gene expression analyses of extracellular matrix (ECM)-related markers were not included in the present study. Given the critical role of ECM components in neurite outgrowth, synaptic stability, and stem cell-mediated regeneration, future studies incorporating quantitative PCR or transcriptomic approaches would provide valuable insight into ECM remodeling induced by PBM-preconditioned hMSC spheroids. Fourth, the present study is limited by the absence of <italic>in vivo</italic> validation, as all findings were derived from an <italic>in vitro</italic> co-culture system. This experimental design was intentionally chosen to establish a controlled proof-of-concept platform that enables systematic evaluation of PBM-preconditioned hMSC spheroids and their paracrine-mediated effects on injured neurons. Although the observed <italic>in vitro</italic> neuroprotective and regenerative effects are encouraging, they do not directly predict therapeutic efficacy <italic>in vivo</italic>. Future studies employing relevant animal models of neural injury, such as spinal cord injury or ischemic stroke, will be essential to validate the translational potential of this approach (<xref ref-type="bibr" rid="ref15">He et al., 2019</xref>). In addition, hMSCs used in this study were derived from a single donor, which may limit the generalizability of the findings due to donor-to-donor variability in proliferation capacity and secretory profiles. However, the use of a single donor allowed controlled within-sample comparisons of PBM effects and minimized confounding biological variability. Future studies incorporating hMSCs from multiple donors of different ages and backgrounds will be necessary to validate the reproducibility and robustness of the observed effects.</p>
<p>In conclusion, this study supports the use of PBM-preconditioned hMSC spheroids as a viable therapeutic strategy for neural repair under oxidative stress conditions. The results highlight the additive benefits of combining PBM with 3D spheroid culture, particularly through enhanced mitochondrial metabolism and increased secretion of key neuroregenerative factors. The observed wavelength-specific effects, especially the superiority of 850&#x202F;nm light, emphasize the importance of carefully selecting PBM parameters to maximize efficacy. These findings align with broader efforts in regenerative neuroscience to develop stem cell-based interventions for conditions such as stroke, spinal cord injury, and neurodegenerative diseases (<xref ref-type="bibr" rid="ref28">Lunken et al., 2023</xref>). Future research should focus on elucidating the molecular mechanisms involved, optimizing PBM protocols, and validating these approaches in preclinical models to facilitate clinical translation.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec16">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec17">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Institutional Review Board of Dankook University Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. The animal study was approved by Institutional Animal Care and Use Committee (IACUC) of Dankook University Medical School. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec18">
<title>Author contributions</title>
<p>S-YC: Writing &#x2013; original draft. NH: Writing &#x2013; original draft. JC: Writing &#x2013; review &#x0026; editing. J-CA: Writing &#x2013; review &#x0026; editing. ML: Writing &#x2013; original draft.</p>
</sec>
<sec sec-type="COI-statement" id="sec19">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec20">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec21">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec22">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fncel.2026.1728579/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fncel.2026.1728579/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Presentation_1.PPTX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.presentationml.presentation" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abueva</surname><given-names>C. D.</given-names></name> <name><surname>Yoon</surname><given-names>S. R.</given-names></name> <name><surname>Carpena</surname><given-names>N. T.</given-names></name> <name><surname>Ahn</surname><given-names>S. C.</given-names></name> <name><surname>Chang</surname><given-names>S. Y.</given-names></name> <name><surname>Choi</surname><given-names>J. E.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Development of NIR photocleavable nanoparticles with BDNF for vestibular neuron regeneration</article-title>. <source>J Nanobiotechnol.</source> <volume>23</volume>:<fpage>209</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12951-025-03298-x</pub-id></mixed-citation></ref>
<ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrzejewska</surname><given-names>A.</given-names></name> <name><surname>Dabrowska</surname><given-names>S.</given-names></name> <name><surname>Lukomska</surname><given-names>B.</given-names></name> <name><surname>Janowski</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Mesenchymal stem cells for neurological disorders</article-title>. <source>Adv Sci (Weinh)</source> <volume>8</volume>:<fpage>2002944</fpage>. doi: <pub-id pub-id-type="doi">10.1002/advs.202002944</pub-id>, <pub-id pub-id-type="pmid">33854883</pub-id></mixed-citation></ref>
<ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arslan</surname><given-names>H.</given-names></name> <name><surname>&#x00D6;zdemir</surname><given-names>M.</given-names></name> <name><surname>Kavak</surname><given-names>R. P.</given-names></name> <name><surname>Kesero&#x011F;lu</surname><given-names>K.</given-names></name> <name><surname>Mutlu</surname><given-names>M.</given-names></name> <name><surname>Korkmaz</surname><given-names>M. H.</given-names></name></person-group> (<year>2024</year>). <article-title>Can Cochlear nerve size assessment with magnetic resonance enhance the understanding of idiopathic sudden sensorineural hearing loss?</article-title> <source>J Audiol Otol</source> <volume>28</volume>, <fpage>29</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.7874/jao.2023.00164</pub-id>, <pub-id pub-id-type="pmid">37857369</pub-id></mixed-citation></ref>
<ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpena</surname><given-names>N. T.</given-names></name> <name><surname>Chang</surname><given-names>S. Y.</given-names></name> <name><surname>Mun</surname><given-names>S.</given-names></name> <name><surname>Kim</surname><given-names>K. W.</given-names></name> <name><surname>Yoon</surname><given-names>H. C.</given-names></name> <name><surname>Chung</surname><given-names>P. S.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Shh agonist enhances maturation in homotypic Lgr5-positive inner ear organoids</article-title>. <source>Theranostics</source> <volume>15</volume>, <fpage>5543</fpage>&#x2013;<lpage>5565</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.107345</pub-id>, <pub-id pub-id-type="pmid">40365278</pub-id></mixed-citation></ref>
<ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>K.</given-names></name> <name><surname>Lee</surname><given-names>H. J.</given-names></name> <name><surname>Na</surname><given-names>K. S.</given-names></name> <name><surname>Fernandes-Cunha</surname><given-names>G. M.</given-names></name> <name><surname>Blanco</surname><given-names>I. J.</given-names></name> <name><surname>Djalilian</surname><given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Characterizing the impact of 2D and 3D culture conditions on the therapeutic effects of human mesenchymal stem cell secretome on corneal wound healing in vitro and ex vivo</article-title>. <source>Acta Biomater.</source> <volume>99</volume>, <fpage>247</fpage>&#x2013;<lpage>257</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actbio.2019.09.022</pub-id>, <pub-id pub-id-type="pmid">31539656</pub-id></mixed-citation></ref>
<ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Enhanced inner-ear organoid formation from mouse embryonic stem cells by Photobiomodulation</article-title>. <source>Mol Ther Methods Clin Dev</source> <volume>17</volume>, <fpage>556</fpage>&#x2013;<lpage>567</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.omtm.2020.03.010</pub-id></mixed-citation></ref>
<ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Photobiomodulation can enhance stem cell viability in cochlea with auditory neuropathy but does not restore hearing</article-title>. <source>Stem Cells Int.</source> <volume>2023</volume>:<fpage>6845571</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2023/6845571</pub-id></mixed-citation></ref>
<ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. Y.</given-names></name> <name><surname>Lee</surname><given-names>M. Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Photobiomodulation with a wavelength &#x003E; 800 nm induces morphological changes in stem cells within otic organoids and scala media of the cochlea</article-title>. <source>Lasers Med. Sci.</source> <volume>36</volume>, <fpage>1917</fpage>&#x2013;<lpage>1925</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10103-021-03268-3</pub-id></mixed-citation></ref>
<ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. Y.</given-names></name> <name><surname>Lee</surname><given-names>M. Y.</given-names></name> <name><surname>Chung</surname><given-names>P. S.</given-names></name> <name><surname>Kim</surname><given-names>S.</given-names></name> <name><surname>Choi</surname><given-names>B.</given-names></name> <name><surname>Suh</surname><given-names>M. W.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Enhanced mitochondrial membrane potential and ATP synthesis by photobiomodulation increases viability of the auditory cell line after gentamicin-induced intrinsic apoptosis</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>19248</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-55711-9</pub-id>, <pub-id pub-id-type="pmid">31848399</pub-id></mixed-citation></ref>
<ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>S. Y.</given-names></name> <name><surname>Lee</surname><given-names>J. H.</given-names></name> <name><surname>Oh</surname><given-names>S. C.</given-names></name> <name><surname>Lee</surname><given-names>M. Y.</given-names></name> <name><surname>Lim</surname><given-names>N. K.</given-names></name></person-group> (<year>2023</year>). <article-title>Human fibroblast growth factor-treated adipose-derived stem cells facilitate wound healing and revascularization in rats with Streptozotocin-induced diabetes mellitus</article-title>. <source>Cells</source> <volume>12</volume>:<fpage>1146</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells12081146</pub-id></mixed-citation></ref>
<ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L. F.</given-names></name> <name><surname>Knelson</surname><given-names>L. P.</given-names></name> <name><surname>Gergen</surname><given-names>M. F.</given-names></name> <name><surname>Better</surname><given-names>O. M.</given-names></name> <name><surname>Nicholson</surname><given-names>B. P.</given-names></name> <name><surname>Woods</surname><given-names>C. W.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>A prospective study of transmission of multidrug-resistant organisms (MDROs) between environmental sites and hospitalized patients-the TransFER study</article-title>. <source>Infect. Control Hosp. Epidemiol.</source> <volume>40</volume>, <fpage>47</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1017/ice.2018.275</pub-id>, <pub-id pub-id-type="pmid">30426908</pub-id></mixed-citation></ref>
<ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>F.</given-names></name> <name><surname>Oliveira</surname><given-names>S.</given-names></name> <name><surname>Monteiro</surname><given-names>F.</given-names></name> <name><surname>Gasik</surname><given-names>M.</given-names></name> <name><surname>Silva</surname><given-names>F. S.</given-names></name> <name><surname>Sousa</surname><given-names>N.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Devices used for photobiomodulation of the brain-a comprehensive and systematic review</article-title>. <source>J. Neuroeng. Rehabil.</source> <volume>21</volume>:<fpage>53</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12984-024-01351-8</pub-id>, <pub-id pub-id-type="pmid">38600582</pub-id></mixed-citation></ref>
<ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>S.</given-names></name> <name><surname>Hamblin</surname><given-names>M. R.</given-names></name> <name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Differentiation of mesenchymal stem cells to neuroglia: in the context of cell Signalling</article-title>. <source>Stem Cell Rev. Rep.</source> <volume>15</volume>, <fpage>814</fpage>&#x2013;<lpage>826</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12015-019-09917-z</pub-id>, <pub-id pub-id-type="pmid">31515658</pub-id></mixed-citation></ref>
<ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamblin</surname><given-names>M. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Mechanisms and mitochondrial redox signaling in Photobiomodulation</article-title>. <source>Photochem. Photobiol.</source> <volume>94</volume>, <fpage>199</fpage>&#x2013;<lpage>212</lpage>. doi: <pub-id pub-id-type="doi">10.1111/php.12864</pub-id>, <pub-id pub-id-type="pmid">29164625</pub-id></mixed-citation></ref>
<ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W. M.</given-names></name> <name><surname>Ying-Fu</surname><given-names>L.</given-names></name> <name><surname>Wang</surname><given-names>H.</given-names></name> <name><surname>Peng</surname><given-names>Y. P.</given-names></name></person-group> (<year>2019</year>). <article-title>Delayed treatment of alpha5 GABAA receptor inverse agonist improves functional recovery by enhancing neurogenesis after cerebral ischemia-reperfusion injury in rat MCAO model</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>2287</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-38750-0</pub-id>, <pub-id pub-id-type="pmid">30783142</pub-id></mixed-citation></ref>
<ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>S. J.</given-names></name> <name><surname>Hopkins</surname><given-names>D. J.</given-names></name> <name><surname>Huber</surname><given-names>G. A.</given-names></name></person-group> (<year>2021</year>). <article-title>Not by turnout alone: measuring the sources of electoral change, 2012 to 2016</article-title>. <source>Sci. Adv.</source> <volume>7</volume>:<fpage>eabe3272</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.abe3272</pub-id></mixed-citation></ref>
<ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>N.</given-names></name> <name><surname>Kang</surname><given-names>G. W.</given-names></name> <name><surname>Park</surname><given-names>J. O.</given-names></name> <name><surname>Chung</surname><given-names>P. S.</given-names></name> <name><surname>Lee</surname><given-names>M. Y.</given-names></name> <name><surname>Ahn</surname><given-names>J. C.</given-names></name></person-group> (<year>2022</year>). <article-title>Photobiomodulation regulates adult neurogenesis in the hippocampus in a status epilepticus animal model</article-title>. <source>Sci. Rep.</source> <volume>12</volume>:<fpage>15246</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-022-19607-5</pub-id></mixed-citation></ref>
<ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>N.</given-names></name> <name><surname>Kim</surname><given-names>H. J.</given-names></name> <name><surname>Kang</surname><given-names>K.</given-names></name> <name><surname>Park</surname><given-names>J. O.</given-names></name> <name><surname>Mun</surname><given-names>S.</given-names></name> <name><surname>Kim</surname><given-names>H. G.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Photobiomodulation improves the synapses and cognitive function and ameliorates epileptic seizure by inhibiting downregulation of Nlgn3</article-title>. <source>Cell Biosci.</source> <volume>13</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13578-022-00949-6</pub-id>, <pub-id pub-id-type="pmid">36635704</pub-id></mixed-citation></ref>
<ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>G.</given-names></name> <name><surname>Ashvetiya</surname><given-names>T.</given-names></name> <name><surname>Leszczynska</surname><given-names>A.</given-names></name> <name><surname>Yang</surname><given-names>W.</given-names></name> <name><surname>Hwang</surname><given-names>C. W.</given-names></name> <name><surname>Gerstenblith</surname><given-names>G.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Paracrine-mediated rejuvenation of aged mesenchymal stem cells is associated with downregulation of the autophagy-lysosomal pathway</article-title>. <source>NPJ Aging</source> <volume>8</volume>:<fpage>10</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41514-022-00091-0</pub-id>, <pub-id pub-id-type="pmid">35927427</pub-id></mixed-citation></ref>
<ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isakovic</surname><given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Mesenchymal stem cell therapy for neurological disorders: the light or the dark side of the force?</article-title> <source>Front. Bioeng. Biotechnol.</source> <volume>11</volume>:<fpage>1139359</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fbioe.2023.1139359</pub-id></mixed-citation></ref>
<ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaukovic</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Specificity of 3D MSC spheroids microenvironment: impact on MSC behavior and properties</article-title>. <source>Stem Cell Rev. Rep.</source> <volume>16</volume>:<fpage>32681232</fpage>, <fpage>853</fpage>&#x2013;<lpage>875</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12015-020-10006-9</pub-id></mixed-citation></ref>
<ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. H.</given-names></name> <name><surname>Kwak</surname><given-names>M. Y.</given-names></name></person-group> (<year>2025</year>). <article-title>Update on medical Management of Acute Peripheral Facial Palsy</article-title>. <source>J Audiol Otol</source> <volume>29</volume>, <fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.7874/jao.2024.00731</pub-id>, <pub-id pub-id-type="pmid">39916394</pub-id></mixed-citation></ref>
<ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusuma</surname><given-names>G. D.</given-names></name></person-group> (<year>2022</year>). <article-title>Effect of 2D and 3D culture microenvironments on mesenchymal stem cell-derived extracellular vesicles potencies</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>10</volume>:<fpage>819726</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2022.819726</pub-id></mixed-citation></ref>
<ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvistad</surname><given-names>C. E.</given-names></name> <name><surname>Kr&#x00E5;kenes</surname><given-names>T.</given-names></name> <name><surname>Gavasso</surname><given-names>S.</given-names></name> <name><surname>B&#x00F8;</surname><given-names>L.</given-names></name></person-group> (<year>2024</year>). <article-title>Neural regeneration in the human central nervous system-from understanding the underlying mechanisms to developing treatments. Where do we stand today?</article-title> <source>Front. Neurol.</source> <volume>15</volume>:<fpage>1398089</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2024.1398089</pub-id>, <pub-id pub-id-type="pmid">38803647</pub-id></mixed-citation></ref>
<ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name> <name><surname>Luo</surname><given-names>W.</given-names></name> <name><surname>Xiao</surname><given-names>C.</given-names></name> <name><surname>Zhao</surname><given-names>J.</given-names></name> <name><surname>Xiang</surname><given-names>C.</given-names></name> <name><surname>Liu</surname><given-names>W.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair</article-title>. <source>Theranostics</source> <volume>13</volume>, <fpage>3966</fpage>&#x2013;<lpage>3987</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.84133</pub-id>, <pub-id pub-id-type="pmid">37554275</pub-id></mixed-citation></ref>
<ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name> <name><surname>Wei</surname><given-names>J.</given-names></name> <name><surname>Hei</surname><given-names>J.</given-names></name> <name><surname>Ren</surname><given-names>Y.</given-names></name> <name><surname>Li</surname><given-names>H.</given-names></name></person-group> (<year>2021</year>). <article-title>Long non-coding RNA H19 regulates proliferation of ovarian granulosa cells via STAT3 in polycystic ovarian syndrome</article-title>. <source>Arch. Med. Sci.</source> <volume>17</volume>, <fpage>785</fpage>&#x2013;<lpage>791</lpage>. doi: <pub-id pub-id-type="doi">10.5114/aoms.2019.89254</pub-id>, <pub-id pub-id-type="pmid">34025849</pub-id></mixed-citation></ref>
<ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liechti</surname><given-names>J. I.</given-names></name> <name><surname>Leventhal</surname><given-names>G. E.</given-names></name> <name><surname>Bonhoeffer</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Host population structure impedes reversion to drug sensitivity after discontinuation of treatment</article-title>. <source>PLoS Comput. Biol.</source> <volume>13</volume>:<fpage>e1005704</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005704</pub-id>, <pub-id pub-id-type="pmid">28827796</pub-id></mixed-citation></ref>
<ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunken</surname><given-names>G. R.</given-names></name> <name><surname>Golding</surname><given-names>L.</given-names></name> <name><surname>Schick</surname><given-names>A.</given-names></name> <name><surname>Majdoubi</surname><given-names>A.</given-names></name> <name><surname>Lavoie</surname><given-names>P. M.</given-names></name> <name><surname>Vallance</surname><given-names>B. A.</given-names></name></person-group> (<year>2023</year>). <article-title>Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination</article-title>. <source>Gut</source> <volume>73</volume>, <fpage>208</fpage>&#x2013;<lpage>210</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gutjnl-2022-328556</pub-id>, <pub-id pub-id-type="pmid">36549875</pub-id></mixed-citation></ref>
<ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monika</surname><given-names>M.</given-names></name> <name><surname>Anna</surname><given-names>K. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Nut oils and their dietetic and cosmetic significance: a review</article-title>. <source>J. Oleo Sci.</source> <volume>68</volume>, <fpage>111</fpage>&#x2013;<lpage>120</lpage>. doi: <pub-id pub-id-type="doi">10.5650/jos.ess18216</pub-id>, <pub-id pub-id-type="pmid">30651417</pub-id></mixed-citation></ref>
<ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>External ankle taping does not alter lower extremity side-step cut and straight sprint biomechanics in young adult males</article-title>. <source>Sports Biomech.</source> <volume>19</volume>, <fpage>395</fpage>&#x2013;<lpage>410</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14763141.2018.1493743</pub-id></mixed-citation></ref>
<ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulaudzi</surname><given-names>P. E.</given-names></name> <name><surname>Abrahamse</surname><given-names>H.</given-names></name> <name><surname>Crous</surname><given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Impact of photobiomodulation on neural embryoid body formation from immortalized adipose-derived stem cells</article-title>. <source>Stem Cell Res Ther</source> <volume>15</volume>:<fpage>489</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13287-024-04088-2</pub-id>, <pub-id pub-id-type="pmid">39707453</pub-id></mixed-citation></ref>
<ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H. J.</given-names></name></person-group> (<year>2022</year>). <article-title>Treatment with light-emitting diodes of wavelength 863 nm delays DMBA/TPA-induced skin tumor formation and decreases Proinflammatory cytokine levels in ICR mice</article-title>. <source>Biomed. Res. Int.</source> <volume>2022</volume>:<fpage>4400276</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2022/4400276</pub-id></mixed-citation></ref>
<ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>G.</given-names></name> <name><surname>Avila</surname><given-names>J.</given-names></name> <name><surname>Tabaton</surname><given-names>M.</given-names></name> <name><surname>Zhu</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Birth of JAD: 20 years later</article-title>. <source>J Alzheimer's Dis</source> <volume>62</volume>:<fpage>901</fpage>. doi: <pub-id pub-id-type="doi">10.3233/JAD-180120</pub-id>, <pub-id pub-id-type="pmid">29562547</pub-id></mixed-citation></ref>
<ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrenko</surname><given-names>Y.</given-names></name> <name><surname>Sykova</surname><given-names>E.</given-names></name> <name><surname>Kubinova</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids</article-title>. <source>Stem Cell Res Ther</source> <volume>8</volume>:<fpage>94</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13287-017-0558-6</pub-id></mixed-citation></ref>
<ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>J. S.</given-names></name> <name><surname>Zhao</surname><given-names>C.</given-names></name> <name><surname>Wei</surname><given-names>R. H.</given-names></name> <name><surname>Feng</surname><given-names>T.</given-names></name> <name><surname>Bao</surname><given-names>S. S.</given-names></name> <name><surname>Zhao</surname><given-names>W.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Neural regeneration therapy after spinal cord injury induces unique brain functional reorganizations in rhesus monkeys</article-title>. <source>Ann. Med.</source> <volume>54</volume>, <fpage>1867</fpage>&#x2013;<lpage>1883</lpage>. doi: <pub-id pub-id-type="doi">10.1080/07853890.2022.2089728</pub-id>, <pub-id pub-id-type="pmid">35792748</pub-id></mixed-citation></ref>
<ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name> <name><surname>Cao</surname><given-names>Y.</given-names></name> <name><surname>Xie</surname><given-names>W.</given-names></name> <name><surname>Guo</surname><given-names>Y.</given-names></name> <name><surname>Cai</surname><given-names>J.</given-names></name> <name><surname>Huang</surname><given-names>T.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Advances in clinical translation of stem cell-based therapy in neurological diseases</article-title>. <source>J. Cereb. Blood Flow Metab.</source> <volume>45</volume>, <fpage>600</fpage>&#x2013;<lpage>616</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0271678X251317374</pub-id>, <pub-id pub-id-type="pmid">39883811</pub-id></mixed-citation></ref>
<ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney</article-title>. <source>J. Cell. Mol. Med.</source> <volume>20</volume>, <fpage>1203</fpage>&#x2013;<lpage>1213</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.12651</pub-id></mixed-citation></ref>
<ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q.</given-names></name> <name><surname>Hou</surname><given-names>W.</given-names></name> <name><surname>Zhao</surname><given-names>B.</given-names></name> <name><surname>Fan</surname><given-names>P.</given-names></name> <name><surname>Wang</surname><given-names>S.</given-names></name> <name><surname>Wang</surname><given-names>L.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Mesenchymal stem cells lineage and their role in disease development</article-title>. <source>Mol. Med.</source> <volume>30</volume>:<fpage>207</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s10020-024-00967-9</pub-id>, <pub-id pub-id-type="pmid">39523306</pub-id></mixed-citation></ref>
<ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>Z.</given-names></name> <name><surname>Liao</surname><given-names>Y.</given-names></name> <name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Effects of microenvironment and biological behavior on the paracrine function of stem cells</article-title>. <source>Genes Dis</source> <volume>11</volume>, <fpage>135</fpage>&#x2013;<lpage>147</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.gendis.2023.03.013</pub-id>, <pub-id pub-id-type="pmid">37588208</pub-id></mixed-citation></ref>
<ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarahmadi</surname><given-names>A.</given-names></name></person-group> (<year>2025</year>). <article-title>Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond</article-title>. <source>Front. Neurol.</source> <volume>16</volume>:<fpage>1472679</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fneur.2025.1472679</pub-id></mixed-citation></ref>
<ref id="ref41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>B. L.</given-names></name> <name><surname>Hsieh</surname><given-names>C. C.</given-names></name> <name><surname>Hsu</surname><given-names>P. J.</given-names></name> <name><surname>Chang</surname><given-names>C. C.</given-names></name> <name><surname>Wang</surname><given-names>L. T.</given-names></name> <name><surname>Yen</surname><given-names>M. L.</given-names></name></person-group> (<year>2023</year>). <article-title>Three-dimensional spheroid culture of human mesenchymal stem cells: offering therapeutic advantages and in vitro glimpses of the in vivo state</article-title>. <source>Stem Cells Transl. Med.</source> <volume>12</volume>, <fpage>235</fpage>&#x2013;<lpage>244</lpage>. doi: <pub-id pub-id-type="doi">10.1093/stcltm/szad011</pub-id>, <pub-id pub-id-type="pmid">37184894</pub-id></mixed-citation></ref>
<ref id="ref42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>C. W.</given-names></name></person-group> (<year>2023</year>). <article-title>Multipotent mesenchymal stem cell-based therapies for spinal cord injury: current Progress and future prospects</article-title>. <source>Biology (Basel)</source> <volume>12</volume>:<fpage>653</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biology12050653</pub-id></mixed-citation></ref>
<ref id="ref43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name> <name><surname>Zhang</surname><given-names>Z.</given-names></name> <name><surname>Liu</surname><given-names>P.</given-names></name> <name><surname>Xue</surname><given-names>X.</given-names></name> <name><surname>Zhang</surname><given-names>C.</given-names></name> <name><surname>Peng</surname><given-names>L.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>The role of Photobiomodulation to modulate ion channels in the nervous system: a systematic review</article-title>. <source>Cell. Mol. Neurobiol.</source> <volume>44</volume>:<fpage>79</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s10571-024-01513-1</pub-id>, <pub-id pub-id-type="pmid">39579175</pub-id></mixed-citation></ref>
<ref id="ref44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhidu</surname><given-names>S.</given-names></name> <name><surname>Ying</surname><given-names>T.</given-names></name> <name><surname>Rui</surname><given-names>J.</given-names></name> <name><surname>Chao</surname><given-names>Z.</given-names></name></person-group> (<year>2024</year>). <article-title>Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities</article-title>. <source>Stem Cell Res Ther</source> <volume>15</volume>:<fpage>266</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13287-024-03885-z</pub-id>, <pub-id pub-id-type="pmid">39183341</pub-id></mixed-citation></ref>
<ref id="ref45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H.</given-names></name> <name><surname>Yao</surname><given-names>C.</given-names></name> <name><surname>Xu</surname><given-names>Z.</given-names></name> <name><surname>Shang</surname><given-names>G.</given-names></name> <name><surname>Peng</surname><given-names>J.</given-names></name> <name><surname>Xie</surname><given-names>H.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Recent advances in 3D models of the nervous system for neural regeneration research and drug development</article-title>. <source>Acta Biomater.</source> <volume>202</volume>, <fpage>1</fpage>&#x2013;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.actbio.2025.06.013</pub-id>, <pub-id pub-id-type="pmid">40490242</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0002">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/499260/overview">Debora Lo Furno</ext-link>, University of Catania, Italy</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0003">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/554332/overview">Giulia Suarato</ext-link>, National Research Council (CNR), Italy</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1894440/overview">Zhijie Zhu</ext-link>, Fourth Military Medical University, China</p>
</fn>
</fn-group>
</back>
</article>